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Chromatin insulators are regulatory elements that determine domains of genetic functions. We have previously described the characterization
of a 265 bp insulator element, termed sns, localized at the 3V end of the early histone H2A gene of the sea urchin Paracentrotus lividus. This
sequence contains three cis-acting elements (Box A, Box B, and Box C+T) all needed for the enhancer-blocking activity in both sea urchin and
human cells. The goal of this study was to further characterize the sea urchin sns insulator in the erythroid environment. We employed colony
assays in human (K562) and mouse (MEL) erythroid cell lines. We tested the capability of sns to interfere with the communication between the
5VHS2 enhancer of the human h-globin LCR and the g-globin promoter. We found that the sns sequence displays directional enhancer-blocking
activity. By the use of antibodies against known DNA binding proteins, in electrophoretic mobility shift assays, we demonstrated the binding of
the erythroid-specific GATA-1 and the ubiquitous Oct-1 and Sp1 transcription factors. These factors bind to Box A, Box B, and Box C+T,
respectively, in both K562 and MEL nuclear extracts. These results may have significant implications for the conservation of insulator function in
evolutionary distant organisms and may prove to be of practical benefit in gene transfer applications for erythroid disorders such as
hemoglobinopathies and thalassemias.
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Insulators are genetic elements present in a wide range of
eukaryotic organisms capable of attenuating the activity of
enhancers or other regulative elements in a directional manner.
They maintain transcription fidelity by interfering with the
communication between enhancer and promoter only when
interposed between the two [1,2]. Insulators, by restricting
enhancer and silencer function, may impart functional inde-
pendence to transcription units in the eukaryotic genome [3–
10]. It has been suggested that some insulators, such as gypsy
and c-HS4, with their bound proteins, may be tethered at the1079-9796/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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1 These authors contributed equally.nuclear periphery forming loop domains [11,12]. In addition,
insulators may act as barriers to the spreading of heterochro-
matin to euchromatic region [13–17]. Protection from chro-
mosomal silencing requires the constitutive recruitment by the
insulator binding proteins of histone modifying enzymes, such
as H3 lysine 4 methyltransferase and histone acetylases, to
counteract the propagation of condensed chromatin structures
[18–20]. Because of the barrier function, an insulator placed in
flanking location can buffer a transgene from extinction of
expression and also block the passage of regulatory signals
between the transgene and the chromatin domains at the
genomic insertion site.
We have previously described the characterization of the sea
urchin chromosomal insulator, termed sns, localized at the 3V
end of the a-H2A histone gene. When included in artificial
constructs, sns displays directional enhancer-blocking activity
in either orientation, both at early and late developmentaleases 35 (2005) 339 – 344
www.els
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enhancers, only the enhancer located distally from the promoter
with respect to the site of insertion is attenuated [22]. Recent
evidence indicates that sns is part of a DNA fragment, defined
as sns 5, needed for silencing the a-H2A histone gene at
gastrula stage [23]. This result suggests that the sea urchin
insulator, in the natural environment of the histone gene
sequences, is involved in the mechanism of repression.
Remarkably, sns shielded a promoter from the CMV enhancer
in two different human cell lines using plasmid and retroviral
vectors, suggesting that sns maintains the directional enhancer-
blocking function in a human chromatin context [24].
Because of the potential use of sns in gene transfer
experiments in human cells, we carried out functional tests
and DNA binding studies in erythroid cell lines. Here, we
show, by colony assays, that sns maintains its insulator activity
in erythroid milieu, in that it directionally blocks the human
erythroid-specific enhancer 5VHS2 of h-globin LCR in the
interaction with the g-globin promoter in human (K562) and
mouse (MEL) cell lines. In addition, by electrophoretic
mobility shift assays (EMSA), we show that the three cis-
acting elements, essential for the enhancer-blocking activity
[22], bind specific nuclear proteins, both erythroid and
ubiquitous transcription factors.
Materials and methods
Plasmid constructions
The DNA construct pAgNEO that was used for the assembly
of the plasmids for the enhancer-blocking assays and displayed
in Fig. 1 was previously described [25]. To generate plasmid A,
we cloned, upstream to the 1.3 Kb Ag promoter, the 435 bp
EcoRI–EcoRI fragment, containing the sequence essential forFig. 1. Enhancer-blocking assay. The human erythroleukemic cell line K562
was stable transfected by electroporation with the constructs shown on the left.
G418-resistant clones were selected and counted 2 weeks later. The relative
numbers of G418-resistant clones for each construct are shown on the right.
The data shown are the results of six experiments using three different plasmid
preparations. The sea urchin insulator is indicated by I. Enh corresponds to the
human h-globin LCR 435 bp 5V DNAse I hypersensitive site 2 essential for the
enhancer activity. The arrow at the 5V end of the gene labeled NEO indicates the
1.3 kb Ag promoter of the G418 resistance gene. The average of the absolute
numbers of G418-resistant clones for the construct A in the six experiments
was 136, and it was arbitrarily set to 100.the enhancer activity of 5V hypersensitive site-2 (5VHS2) of the
human h-globin LCR. The enhancer-less plasmids (E and F of
Fig. 1) contain two tandem copies of the sea urchin insulator sns
that were cloned, respectively, upstream the Ag promoter and
downstream the NEO coding sequences. In plasmid C, the two
sns sequences were placed flanking the enhancer-less transcrip-
tion unit. Construction of plasmids B and D was carried out in
two steps. We first inserted the 435 bp EcoRI 5VHS2 fragment in
the EcoRI site upstream of the two sns copies of plasmid
pEGFP-2x sns [24]. The 5VHS2-2x sns cassette was then excised
with BglII–BamHI double digestion, filled in with the Klenow
DNA polymerase I, and ligated upstream of the AgNEO gene of
construct F. All DNA constructs were sequenced to determine
the orientation of the inserts.
Transfection and colony assay
Enhancer-blocking assays were performed as described by
Chung et al. with minor modifications [26]. Briefly, 3106
mid-log phase human K562 and mouse MEL erythroleukemia
cells were harvested and washed with phosphate-buffered
saline (PBS) before resuspension in 0.5 ml of cold PBS. 3 Ag of
linearized DNAwas added to the cells. After 10 min on ice, the
cells were electroporated using a Bio-Rad gene pulser at 200 V,
960 AF and stored on ice for 15 min. The transfected cells were
transferred to 35 ml of medium (RPMI for K562 and DMEM
for MEL) containing 10% heat-inactivated fetal calf serum and
aliquoted in four 96-well plates. Neomycin-resistant clones
were selected in 800 Ag/ml G418 (Gibco-BRL) and counted
after 12–14 days.
Nuclear extracts and EMSA analysis
Total nuclear extracts were prepared from several cell lines
as previously described [27]. Protein concentration was
determined by Bradford’s method. EMSA were performed by
incubating 1 ng of 32P-labeled Box A, Box B oligonucleotides,
and Box C+T fragment obtained by PCR as described [22],
with 5 to 10 Ag of total nuclear extracts on ice for 20 min and
then fractionated on 5% polyacrylamide gel in 0.5 TBE. For
competition experiments, nuclear extracts were preincubated
with 20 or 40 ng of unlabeled homologous or heterologous
oligonucleotides. Competition-supershift experiments with
antibody anti-GATA-1, anti-Sp1, anti-Oct-1, and anti-CTCF
(Santa Cruz-Biotechnology) were performed by preincubating
the nuclear extracts on ice for 1 h with 2 Ag of each antibody.
List of oligonucleotides
Only the sense strand is reported.
& Box A: 5V gatccaaacctcaacacctcaacggcccttatcagggccaccaa 3V
& Box B: 5V gatcagtctctgtaattcataatagtctctgtaattcataat 3V
& GATA: 5V atccacactatctcaatgct 3V
& OCT: 5V aactcaatgcaaatatggct 3V
& Sp1: 5V attcgatcggggcggggcgag 3V
& EKLF: 5V gtggagcccacaccctagggtt 3V
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The sea urchin insulator sns attenuates the globin enhancer in
erythroid cell lines in a directional manner
By colony assay [26], we tested whether the sea urchin sns
insulator displays enhancer blocker activity in erythroid
environment. The DNA constructs depicted in Fig. 1 were
derived from the previously described pgNEO plasmid [25]
which contains the neomycin (G418)-resistant gene transcribed
by the 1.3 Kb human Ag-globin promoter. These constructs
were transfected by electroporation in human (K562) and
mouse (MEL) erythroleukemia cell lines, and G418-resistant
clones were counted after 14 days of selection. Six independent
experiments using three different plasmid preparations for each
construct were carried out. The results from K562 are shown in
Fig. 1; similar results were obtained from experiments
performed in MEL cell line (data not shown). Twenty six
individual resistant clones were analyzed by Southern blot to
determine the integrated copy number. From one to three
copies were detected in each clone (data not shown). The
number of G418-resistant clones obtained from each construct
was compared to that of the enhancer-containing construct
(5VHS2-gNEO, construct A) arbitrarily set to 100. The average
of the absolute numbers of G418-resistant clones for the
construct A in the different experiments was 136. To address if
sns element displays enhancer-blocking activity, we con-
structed plasmid B in which two copies of the sns insulator
element were placed between the enhancer and the Ag-globin
promoter. Two additional copies of sns were cloned down-
stream to the NEO coding region to block enhancer function of
a tandem integrant. The results of the enhancer-blocking assay
upon transfection of construct B indicated a 3.5-fold decrease
in the G418-resistant clones (P < 0.001), suggesting that sns
shielded the gNEO reporter gene from the enhancer activity of
the human erythroid-specific LCR when interposed between
the two elements.
The enhancer-less construct (construct C), in which gNEO
gene was flanked by two copies of sns sequence element,
generated a number of clones similar to that of construct B
(P < 0.001), implying that the enhancer-blocking effect of sns
observed for the construct B is almost total. A construct
containing 400 bp plasmid fragment interposed between 5VHS2
enhancer and Ag-globin promoter was used as control. The
number of G418-resistant clones obtained from this construct
was comparable to that of the un-insulated 5VHS2-gNEO
plasmid (data not shown). When the 5VHS2-gNEO transcrip-
tion unit was flanked by two copies of the sea urchin insulator
(construct D), a slight increase of the neomycin-resistant clones
was observed (P < 0.01). To explore if sns has enhancer or
silencer activity per se, we generated constructs E and F where
two copies of insulator element were cloned upstream and
downstream to the reporter gene respectively. The number of
G418-resistant clones generated by these two constructs was
similar to that obtained from gNEO plasmid construct G. From
this result, it is evident that no enhancer or silencer activity can
be assigned to sns element. Altogether, these results demon-strate that the sea urchin insulator sns blocks a tissue-specific
enhancer from the interaction with the promoter in a directional
manner.
The sea urchin sns insulator binds erythroid-specific and
ubiquitous transcription factors
We have previously described three cis-acting sequence
elements, Box A, Box B, and Box C+T, that are each required
for the enhancer-blocking function of sns in sea urchin
embryos and are binding sites for specific protein complexes
[22,23]. Recent evidence indicates that all three sequence
elements are needed for the enhancer-blocking function of sns
in transfected human H1299 cell line (unpublished observa-
tion). Therefore, we addressed the question of whether the
three boxes bind erythroid nuclear factors. Nuclear extracts
were prepared from erythroid MEL and K562 cell lines and
used in electrophoretic mobility shift assays (EMSA). The
specificity of protein–DNA interaction was assessed by
competition in EMSA by using excess of consensus binding
sites for known transcription factors and preincubation of
nuclear extracts with specific antibodies. Assisted computer
analysis revealed that the three sns cis-acting sequence
elements contain putative binding sites for both erythroid-
specific and ubiquitous transcription factors, and we used the
consensus sequence for these factors in competition experi-
ments. The results of the EMSA experiments using 32P-labeled
Box A oligonucleotide are shown in Fig. 2. The Box A formed
a major retarded DNA complex in both erythroid nuclear
extracts that was competed out by 20- to 40-fold excess of
unlabeled Box A (lanes 2 and 10 of Fig. 2). The heterologous
DNA binding sites Box B did not affect nuclear proteins Box A
interaction (lanes 3 and 11 of Fig. 2) and neither did the EKLF
and Oct transcription factor binding sites (lanes 4, 6, 12, and 15
of Fig. 2). Specific competition was instead observed with the
consensus binding site for the erythroid-specific GATA family
transcription factors (lanes 5 and 13 of Fig. 2). The specificity
of interaction of GATA-1 transcription factor was further
demonstrated by the effect of the preincubation of the nuclear
extracts with the antibody anti-GATA-1. We observed in fact
supershift with the MEL extracts (lane 8 of Fig. 2) and
competition with the human K562 proteins (lane 14 of Fig. 2).
As for the Box A, one major and specific retarded DNA–
protein complex was observed when the Box B binding site
was challenged with both the MEL and K562 nuclear extracts
(Figs. 3A and B). The Box B is a direct repeat of AT-rich
sequence [22] and contains a putative binding site for the Oct-1
transcription factor. As expected, full inhibition of the most
retarded complex was observed when the nuclear extracts were
preincubated with molar excess of Box B (lanes 2 and 8 in Fig.
3) and Oct-1 binding sites (lanes 5 and 10 in Fig. 3). A slight
competition was also observed with GATA oligonucleotide in
MEL extracts, but K562 (lanes 4 and 9 in Fig. 3).
The specificity of the complex and the nature of the bound
proteins were also ascertained by monitoring the effect of the
preincubation of the MEL and K562 nuclear extracts with Oct-
1 and GATA-1 antisera. The antiserum against GATA-1 did not
Fig. 2. EMSA analysis of the Box A sequence. Radiolabeled probe Awas incubated with 10 Ag of MEL (lanes 1–8) or 5 Ag of K562 (lanes 9–15) nuclear extracts.
The DNA–protein complexes in the absence of competitors as resolved by polyacrylamide gel electrophoresis are shown in lanes 1, 7, and 9. In competition
experiments, nuclear extracts were preincubated with 40-fold excess (MEL extracts) or 20-fold excess (K562 extracts) unlabeled homologous or heterologous
oligonucleotides. The oligonucleotides containing consensus motifs for the transcription factor recognition sites are indicated above the lanes. Only the GATA
oligonucleotide (lanes 5 and 13) appeared to compete as efficiently as the homologous Box A sequence (lanes 2 and 10). Preincubation of the nuclear extracts with
anti-GATA-1 antibody produced a supershifted complex with the MEL nuclear extracts (lane 8) and inhibition with the K562 nuclear extracts (lane 14). P denotes the
free Box A probe.
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believe that the slight competition observed with the GATA
binding site (lane 4 of Fig. 3) might be due to other GATA
family factors. By contrast, anti-Oct-1 antibody completely
inhibited the formation of the most retarded complex in both
cell lines (lanes 12 and 14 in Fig. 3). In conclusion, the results
of the EMSA shown in Fig. 3 unequivocally identified the Oct-
1 transcription factor as one of the Box B binding proteins.
The third cis-sequence analyzed was the pyrimidine-rich
Box C+T. This sequence interacted with several proteins
forming different complexes. The EMSA pattern of Fig. 4
refers to the MEL nuclear extracts. Identical pattern was
obtained also with the K562 extracts (not shown). In sea
urchin, specific binding occurred with the fourteen CT (GA in
the other strand) repeats of the Box C+T [22]. These CT/GA
repeats did not interact with the erythroid nuclear proteins as
molar excess of the 7-mer GAGA oligonucleotide did not
affect the DNA–protein complexes (lane 3 of Fig. 4). This
result was confirmed by using a shorter C+T oligo, lacking the
CT/GA repeat, which reproduced a specific pattern of retarded
DNA–protein complexes identical to that of the full C+T
DNA fragment (not shown). Of the several DNA binding sitesFig. 3. EMSA analysis of the Box B sequence. Conditions are those described in Fig
Nuclear extracts from MEL (lanes 11–12) and K562 (lanes 13–14) preincubated w
absence of competitors are shown in lanes 1, 6, 11, and 13. Oligonucleotides compe
both Oct-1 binding site (lanes 5 and 10) and anti-Oct-1 antibody (lanes 12 and 14) is
appeared with this nuclear extracts preparation. P denotes the free Box B probe.used in the competition assays, only those for CTCF and Sp1
transcription factors affected the two slower migrating com-
plexes (lanes 2 and 4 of Fig. 4). Because of this observation,
we analyzed the specificity of competition by probing the
nuclear extracts with CTCF and Sp1 antisera. As it is shown in
Fig. 4 (lanes 10 and 12), only the antibody anti-Sp1 efficiently
competed the retarded complexes.
Discussion
The results presented in this paper demonstrate that the sea
urchin chromosomal insulator sns interferes with the interac-
tion of the human h-globin 5VHS2 with the g-globin promoter
in stable transfected erythroid cells. Attenuation of enhancer
function occurs only when sns is interposed between the two
regulatory elements, indicating that the sea urchin sequence
behaves as a positional enhancer blocker also with tissue-
specific transcription sequence elements in an erythroid milieu.
It is of some interest that we reproducibly observe 1.2-fold
increase of G418-resistant clones number upon transfection of
a construct that contains the 5VHS2-gNEO reporter flanked by
two copies of the sea urchin sns element (Fig. 1, construct D).. 2. (A) 10 Ag of MEL nuclear extracts. (B) 5 Ag of K562 nuclear extracts. (C)
ith anti-Oct-1 antibody (lanes 12 and 14). The DNA–protein complexes in the
titors are reported above the lanes. The retarded band specifically competed by
indicated by an arrow. Asterisk refers to a retarded band shown in panel C that
Fig. 4. EMSA analysis of the Box C+T sequence. 5 Ag of MEL nuclear extracts
was incubated with labeled Box C+T probe in the absence (lanes 1 and 9) or in
the presence of 20-fold excess of oligonucleotides competitors. Oligonucleo-
tides competitors for transcription factors anti-CTCF and anti-Sp1 antibodies
are reported above the lanes. CTCF and Sp1 binding sites competed the
retarded complexes (lanes 2, 4, and 11). The antibody against Sp1 inhibited the
specific protein–DNA interaction (lane 12). P denotes the free Box C+T
probe.
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demonstrate that the sea urchin insulator has a neutral role on
the transcriptional activation of the gNEO gene by the
erythroid-specific enhancer. In addition, sns might protect the
transgene from position effects of the surrounding chromatin at
the integration site, suggesting a possible barrier function for
the sns element in erythroid cells. These findings are in
agreement with our recent observations that the sea urchin sns
5 fragment, which includes sns, involved in the silencing of the
H2A histone gene in sea urchin [23], is capable of reducing the
influence of the chromatin environment on an integrated
retroviral transgene (unpublished results). The observation that
only a slight rise in the number of neomycin-resistant clones is
generated by construct D is in line with the evidence that the
chicken h-globin 5VHS4 (cHS4) insulator also does not
improve gene expression and position effect protection when
it is in the presence of a strong enhancer [28,29]. This is also
consistent with the demonstration that transcription factors may
contribute in the establishment of an active domain that is
independent of the influence of flanking chromatin [30].
The activity of chromosomal insulators depends on the
binding of nuclear proteins. We have shown here that, in vitro,
the sns insulator binds transcription factors whose binding sites
are located in the previously identified sequence elements
needed for the directional enhancer-blocking activity in sea
urchin and human cells [22]. The use of antiserum against
transcription factors whose binding sites inhibited the forma-
tion of specific retarded complexes indisputably allowed the
identification of GATA-1, Oct-1, and Sp1 activators as the
binding proteins, respectively, to the Box A, Box B, and Box
C+T. Of the three transcription factors, GATA-1 is erythroid-
specific. Chromatin immunoprecipitation analysis is in prog-
ress to confirm the binding of these transcription factors to sns
sequences in vivo. The binding of transcription factors to a
genomic insulator is not surprising. The prototypic vertebrate
insulator c-HS4 binds two known transcription factors, CTCF,
required for the directional enhancer-blocking activity [28], andUSF, involved in the barrier function [18]. In addition, some
reports have demonstrated that a variety of transcription
activation domains tethered to tandem DNA sites can
reconstitute bona fide insulator in yeast and mammals
[30,31]. It remains to be established how transcription factors
bound to the sns insulator can block the interaction between the
h-globin LCR and g-globin promoter and at the same time
have a neutral role on the expression of the reporter transgene.
In conclusion, our results have significant implications for the
evolutionary conservation of insulator function from sea urchin
to man.
Silencing and position effect are considered significant
obstacles to obtain a consistent level of transgene expression in
viral gene therapy [32]. Furthermore, recent studies have
shown insertional activation of an adjacent oncogene upon
integration in the genome of retroviral vectors in a gene therapy
protocol against an immune disease [33]. The design and
incorporation of effective chromatin insulator sequences in the
next generation of gene therapy vectors should be helpful in
reducing these unwanted side-effects. The relatively small size
of the sea urchin insulator sns, the apparent absence of
enhancer and cell specificity, as well as the capability to bind
tissue and ubiquitous transcription factors may prove to be of
practical benefit for the development of vectors in gene transfer
application for erythroid disorders such as hemoglobinopathies
and thalassemias.
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